Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma

C. Querfeld; T. M. Kuzel; J. Guitart; S. T. Rosen

Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma

C. Querfeld^*, T. M. Kuzel, J. Guitart, S. T. Rosen

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	38-39
Number of pages	2
Journal	Haematologica Reports
Volume	2
Issue number	13
State	Published - Dec 1 2006

ASJC Scopus subject areas

Hematology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{998f05a1c2a04acdae213488607a6ff8,

title = "Lenalidomide (Revlimid{\textregistered}) in patients with cutaneous T-cell lymphoma",

author = "C. Querfeld and Kuzel, {T. M.} and J. Guitart and Rosen, {S. T.}",

year = "2006",

month = dec,

day = "1",

language = "English (US)",

volume = "2",

pages = "38--39",

journal = "Haematologica Reports",

issn = "1824-9337",

publisher = "Fondazione Ferrata Storti Onlus",

number = "13",

}

TY - JOUR

T1 - Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma

AU - Querfeld, C.

AU - Kuzel, T. M.

AU - Guitart, J.

AU - Rosen, S. T.

PY - 2006/12/1

Y1 - 2006/12/1

UR - http://www.scopus.com/inward/record.url?scp=46849108946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849108946&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:46849108946

SN - 1824-9337

VL - 2

SP - 38

EP - 39

JO - Haematologica Reports

JF - Haematologica Reports

IS - 13

ER -

Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this